Agilent 1100 Series Analysis of Antiestrogen Drugs by HPLC Application Note

The HPLC method for analysis of antiestrogen drugs is described in this document.

Brand: Analysis
Category: Other
Document type: Application Note
Language: English
Pages: 2
File format: PDF
File size: 28 KB
Published: 03 July, 2012
Updated: 30 September, 2023
Model: 1100 Series
MD5 checksum: 24E9D538B504294C07F3A33D9E7ED910
PDF: Agilent 1100 Series Analysis of Antiestrogen Drugs by HPLC Application Note PDF

About this manual

This document presents an HPLC method for the analysis of antiestrogen drugs, specifically focusing on tamoxifen. The method utilizes a reversed-phase column and UV detection to inhibit the biosynthesis of estrogen, which is relevant for treating certain tumors like breast cancer. The analysis involves a gradient elution with a mobile phase of phosphate buffer and acetonitrile.

What's inside

Abstract
Conditions
Figure 1 Analysis of tamoxifen
Performance Table
Equipment
Columns

Specifications

Column	Purospher RP-18 5 um 4 x 125 mm
Mobile phase A	0.025 M KH2PO4 in water (pH = 3)
Mobile phase B	acetonitrile
Flow rate	1.0 ml/min
Gradient	20 % B to 60 % B in 14 min
Column wash	60 % B to 20 % B in 2 min
UV detector wavelength	204 nm
Column temperature	60 °C
Injection volume	5 ul
Stop time	16 min
Post time	5 min
LOD for Tamoxifen	0.2 mg/l

Frequently asked questions

What is the purpose of the HPLC method described?

The method is used to analyze antiestrogen drugs, specifically tamoxifen, to inhibit the biosynthesis of estrogen from testosterone.

What is the recommended column for this analysis?

The recommended column is Purospher RP-18, 5 um, 4x 125 mm.

What is the flow rate for the HPLC analysis?

The flow rate is set to 1.0 ml/min.

What is the limit of detection (LOD) for tamoxifen?

The LOD for tamoxifen is 0.2 mg/l.

Download PDF (28 KB)